Prolific Machines brings 1 presentation to BPI 2026 in Boston, and exhibits at Booth 1737. Prolific Machines develops a light-controlled cell engineering platform for cell line development and biologics production. Its session asks whether cell lines for multispecifics and gene therapy are stuck in monoclonal antibody thinking.
| Organization | BPI 2026 Attendance |
|---|---|
Prolific Machines Emeryville, California | 1 Head of Optogenetics |
Developer of a light-controlled (optogenetic) cell engineering platform for cell line development and production of antibodies and other biologics. | Booth Exhibiting at Booth 1737 Wed, Sep 233:30pm–7:00pmThu, Sep 248:15am–5:00pmFri, Sep 259:00am–1:50pm |
Instantly find 20 buyers from Prolific Machines
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Informa Connect or the BioProcess International Conference & Exhibition. Submit a correction